rdf:type |
|
lifeskim:mentions |
umls-concept:C0007082,
umls-concept:C0030685,
umls-concept:C0086418,
umls-concept:C0205266,
umls-concept:C0229671,
umls-concept:C0391871,
umls-concept:C0431085,
umls-concept:C0443348,
umls-concept:C0680255,
umls-concept:C1283071,
umls-concept:C1293122,
umls-concept:C1521761,
umls-concept:C1963578
|
pubmed:issue |
4
|
pubmed:dateCreated |
1995-10-26
|
pubmed:abstractText |
Measurement of carcinoembryonic antigen (CEA) levels in human serum is frequently used to detect tumor recurrence in patients with resected primary colorectal cancers. These levels are highly variable from patient to patient, and the mechanism that determines these levels is still poorly understood.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
1068-9265
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
2
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
336-42
|
pubmed:dateRevised |
2007-7-18
|
pubmed:meshHeading |
|
pubmed:year |
1995
|
pubmed:articleTitle |
Augmentation of carcinoembryonic antigen release from intact, viable tumor cells by a factor in human serum.
|
pubmed:affiliation |
Department of Surgery, H. Lee Moffitt Cancer Center and Research Institute, University of South Florida, College of Medicine, Tampa 33612, USA.
|
pubmed:publicationType |
Journal Article,
Comparative Study
|